skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Download Article Pack

The resignation of US Food & Drug Administration (FDA) head Scott Gottlieb recently sent shockwaves through biopharma, where the Commissioner had been popular for his market-based policies to lower drug costs and his work to speed new brands to approval. Keep track of the latest developments surrounding his departure, what it means for the future of the drug market in the US, and who is being tapped as his replacement, with comprehensive, critical coverage from Pink Sheet.

Read also


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free   : +1 888 670 8900  
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (20) 805 20700

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: